Skip to content
Clinical Trials – home

Pirkanmaan hyvinvointialue

Verifiedinfo

Finland Elamanaukio 2, 33520 Tampere, Finland

  • 93 trials recruiting
  • Endometrial cancer · Acute myeloid leukaemia · Breast cancer
  • Adults and children

About Specializations

Pirkanmaan hyvinvointialue in Tampere, Finland specialises in clinical trials of conditions such as Endometrial cancer, Acute myeloid leukaemia, Breast cancer, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases

The Pirkanmaan hyvinvointialue research center in Tampere concentrates its clinical programs on Nervous System Diseases, primarily exploring treatments for multiple sclerosis.

  • Relapsing multiple sclerosis
  • Progressive multiple sclerosis
  • Long‑term safety and tolerability evaluation
  • Investigation of novel BTK inhibitors
  • Patient‑focused outcome measures

Across five active trials, a team of 74 investigators is assessing the safety profile of new therapies such as tolebrutinib to expand treatment options for individuals living with multiple sclerosis. The work aims to enhance long‑term disease management and improve quality of life for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Elamanaukio 233520 TampereFinland
Recruiting now
93 trials
Conditions studied
149
Partner status
Verified

More sites in TampereFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

182 clinical trials

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited

Bronchiectasis

Recruiting
Investigational
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Narcolepsy

Recruiting
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
  • Sponsor:Takeda Development Center Americas Inc.

Coeliac disease

Recruiting
Investigational
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.